why choose us

First received: January 19, 2023

Clinical Trial: A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack- LIBREXIA-STROKE

Study Status: Completed

Recruit Status: RECRUITING

Condition: Ischemic Stroke; Ischemic Attack, Transient

Study Type: INTERVENTIONAL


Official Title: A Phase 3, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, for Stroke Prevention After an Acute Is

Brief Summary: The purpose of this study is to evaluate whether milvexian compared to placebo reduce the risk of recurrent ischemic stroke.

Read more